USPTO serial 79372665
SYMATESE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 29, 2026
- Examiner
- LADNER, CHRISTOPHER G
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SYMATESE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JANET G RICCIUTI
JANET G RICCIUTI JANET GILBERT RICCIUTI PC2003 Kalorama Road NW50 Chemin de la BruyèreWASHINGTON, DC 20009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the filling of wrinkles, the reshaping of the shapes and volumes of the face, the neck, the decolletage and the hands and for mesotherapy; pharmaceutical products for regeneration of the skin or tissue or bones; pharmaceutical products for ophthalmological use; pharmaceutical products for treating joint pain ; pharmaceutical products for urology use; pharmaceutical products for reducing side effect of irradiation on nearby tissue during cancer treatment; medical preparations for the filling of wrinkles, the reshaping of the shapes and volumes of the face, the neck, the decolletage and the hands and for mesotherapy; medical products for the regeneration of the skin or tissue or bones; medical preparations for the treatment of ophthalmological conditions; medical preparations for the treatment of joint pain ; medical preparations for the treatment of urology conditions; medical preparations for the treatment of reducing side effect of irradiation on nearby tissue during cancer treatment; surgical products being injectable dermal filler for the filling of wrinkles, the reshaping of the shapes and volumes of the face, the neck, the decolletage and the hands and for mesotherapy; surgical products being biological tissue grafts for use in the regeneration of the skin or tissue or bones; surgical products being surgical dressings for ophthalmological use; surgical products being anesthetic for surgical purposes for treating joint pain ; surgical products being anesthetic for surgical purposes for treatment of urology conditions ; surgical products being biological tissue grafts for reducing side effect of irradiation on nearby tissue during cancer treatment; dental products being dental ceramics for the filling of cavities, bone restoration, regeneration of the mucosa; collagen preparations for medical use; surgical dyes, namely, surgical dyes for regeneration of the skin or tissue or bones consisting of collagen ; gels for dermatological use administered by injection for filling in wrinkles, remodeling the shapes and volumes of the face, the neck, the decolletage and the hands, and for medical use for mesotherapy, for ophthalmological use, for treating joint pain, for urology, for reduction of side effect for irradiation on nearby tissue during cancer treatment; surgical implants composed of living tissue; cutaneous anesthetic for surgical purposes; surgical and medical dressings and gauze, bandage, wadding for dressings; biological preparations for the treatment of wrinkles, reshaping of the shapes and volumes of the face and neck, regeneration of the skin or tissue or bones, ophthalmological use, treating joint pain, urology use, reducing side effect of irradiation on nearby tissue during cancer treatment, for medical use; surgical adhesive bandages; medicated skin healing compresses; medicated compresses; collagen compresses for medical and surgical applications; oxidized cellulose hemostatic compresses for medical and surgical applications; bone cement for surgical and orthopedic purposes; dental cements; adhesives bandages and cements for bones for medical use; medical and surgical plasters; surgical cloth bandages; sanitary products, namely sanitary preparations, sanitary sterilizing preparations for medical purposes; dermatological preparations | ACTIVE | — |
| 010 | Surgical apparatus and instruments; medical apparatus and instruments for use in vascular procedure, endovascular procedure, cardiovascular procedure, endoscopy procedure, visceral procedure, dental procedure, maxillofacial procedure, orthopaedical procedure, dermatological procedure, dermal reconstruction and regeneration procedure, aesthetic procedure, plastic and reconstructive procedure, spine procedure, ophthalmological procedure, urological procedure, rheumatological procedure, hemostasis; dental apparatus and instruments, namely, oral irrigators, dental bone plugs of synthetic materials, dental drill bits, filling instruments for dental purposes, administration systems, syringes, injectors; ophthalmic apparatus and instruments, namely, administration systems, syringes, injectors, cartridges; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic joint implants, bone repair compound for use in orthopedic surgery, orthopedic implants composed of metal, orthopedic internal fixation implants composed of artificial materials ; orthopedic articles namely orthopedic implants made of artificial materials, bone void fillers consisting of artificial materials, bone substitutes; suture material; artificial hip implants; artificial implants consisting of artificial materials; artificial breast implants; biodegradable bone fixation implants ; biodegradable implants for use in orthopedic, ophthalmic, dental, urologic, aesthetic, plastic and reconstructive surgery; medical devices for use in treating temporomandibular joint disorder, respiratory diseases, rheumatoid arthritis, burns, amputations, regeneration of the skin or tissue or bones; medical devices, namely, implant injectors; artificial skin for surgical use; elastic bandages; post-operative compression garments, also for medical treatment; elastic stockings for surgical purposes; catheters; needles for medical and surgical use; stents for the treatment of vascular endoprostheses; artificial cardiac valves, namely, heart valves; medical devices for use in treating vascular issues, namely vein stripper pumps; devices for the diversion of blood flow, namely, hepatic shunt occluders; endoprostheses and implantable catheter chambers; angioplasty medical balloons; bone, joint, hip, dental, breast prostheses; vascular prostheses; medical and surgical devices for vascular access; microdermabrasion apparatus for medical or therapeutic purpose; ophthalmometers; ophthalmoscopes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 29, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 11, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 5, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 8, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 17, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 17, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 17, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 12, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 17, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 17, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 7, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 7, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 7, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 6, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2024 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Nov 21, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 21, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 21, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 21, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 16, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 15, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2024 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Oct 26, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2024 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Oct 5, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2024 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Feb 24, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 23, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 15, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 5, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 22, 2023 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |